| KOTAK HEALTHCARE FUND
An open ended equity scheme investing in Pharma, Healthcare & allied sectors.
| KOTAK HEALTHCARE FUND
An open ended equity scheme investing in Pharma, Healthcare & allied sectors.

  

  
Investment Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved.

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved.


Issuer/Instrument
% to Net
Assets

Equity & Equity related
Pharmaceuticals and Biotechnology 70.99
Sun Pharmaceuticals Industries Ltd. 14.78
Divi s Laboratories Ltd. 6.01
Cipla Ltd. 4.98
JUBILANT PHARMOVA LIMITED 3.74
JB CHEMICALS & PHARMACEUTICALS LTD. 3.52
Torrent Pharmaceuticals Ltd. 3.16
Lupin Ltd. 3.08
GLAND PHARMA LIMITED 2.83
DR REDDYS LABORATORIES LTD. 2.83
Alkem Laboratories Ltd. 2.61
Marksans Pharma Ltd 2.54
Aurobindo Pharma Ltd. 2.53
Zydus Lifesciences Limited 2.51
ACUTAAS CHEMICALS LTD 2.27
Ajanta Pharma Ltd. 2.24
Glenmark Pharmaceuticals Ltd 2.20
SAI LIFE SCIENCES LIMITED 2.13
MANKIND PHARMA LTD 2.05
INNOVA CAPTABS LTD 1.74
HIKAL LTD 1.66
ORCHID PHARMA LTD. 1.58
Healthcare Services 25.13
MAX HEALTHCARE INSTITUTE LTD. 8.58
Apollo Hospitals Enterprises Ltd. 3.19
Fortis Healthcare India Ltd 3.15
ASTER DM HEALTHCARE LTD 2.83
KRISHNA INSTITUTE OF MEDICAL 2.23
YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD 1.98
RAINBOW CHILDRENS MEDICARE LTD 1.61
KRSNAA DIAGNOSTICS LTD 1.56
Healthcare Equipment and Supplies 2.01
LAXMI DENTAL LIMITED 2.01
Equity & Equity related - Total 98.13
Triparty Repo 2.03
Net Current Assets/(Liabilities) -0.16
Grand Total 100.00



Systematic Investment Plan (SIP) If you had invested Rs 10,000 every month
Monthly SIP of Rs 10000 Since Inception 1 Year
Total amount invested (₹) 1,90,000 1,20,000
Total Value as on June 30, 2025 (₹) 2,10,574 1,23,692
Scheme Returns (%) 13.05 5.81
Nifty Healthcare Index (TRI) Returns (%) 15.72 8.37
Alpha* -2.67 -2.56
Nifty Healthcare Index (TRI) (₹)# 2,14,812 1,25,300
Nifty 50 (TRI) (₹)^ 1,99,403 1,27,838
Nifty 50 (TRI) Returns (%) 5.98 12.45

Scheme Inception : - December 11, 2023. The returns are calculated by XIRR approach assuming investment of ₹10,000/- on the 1st working day of every month. Since Inception returns are assumed to be starting from the inception date of the Scheme and calculated accordingly. XIRR helps in calculating return on investments given an initial and final value and a series of cash inflows and outflows and taking the time of investment into consideration. The SIP performance details provided herein are of Regular Plan - Growth Option Different plans have different expense structure. # Benchmark; ^ Additional Benchmark. TRI – Total Return Index, In terms of para 6.14 of SEBI Master circular No. SEBI/HO/IMD/IMD-PoD-1/P/CIR/2024/90 dated June 27, 2024, the performance of the scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return. *All payouts during the period have been reinvested in the units of the scheme at the then prevailing NAV. Source: ICRA MFI Explorer.

Net Asset Value (NAV)
RegularDirect
Growth Rs13.4470Rs13.7960
IDCW Rs13.4510Rs13.7950
(as on June 30, 2025)

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Growth and Income Distribution cum capital withdrawal (IDCW) (Payout and Reinvestment)


Fund Manager* Ms. Shibani Sircar Kurian,
Mr. Abhishek Bisen &
Mr. Dhananjay Tikariha
BenchmarkNifty Healthcare Index TRI
Allotment dateDecember 11, 2023
AAUMRs442.93 crs
AUMRs453.45 crs
Folio count32,968

IDCW Frequency

Trustee's Discretion


Ratios
Portfolio Turnover31.35%
$Beta0.96
$Sharpe ##0.81
$Standard Deviation17.63%
^^(P/E) 39.61
^^P/BV 5.41
Source: $ICRA MFI Explorer, ^^Bloomberg

Market Capitalisation*
Large Cap34.27%
Mid Cap29.63%
Small Cap34.23%
Debt & Money Market1.87%

*% of Net Asset

Minimum Investment Amount

Initial & Additional Investment
• Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
• Rs 100 and any amount thereafter

Ideal Investments Horizon

• 5 years & above


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load:
• For redemption / switch out within 30 days from the date of allotment: 0.5%
• If units are redeemed or switched out on or after 30 days from the date of allotment: NIL


Total Expense Ratio**
Regular Plan: 2.40%
Direct Plan: 0.79%

Data as on 30th June, 2025 unless otherwise specified.

Folio Count data as on 31st May 2025.

Fund


Benchmark : Nifty Healthcare Index TRI
This product is suitable for investors who are seeking*:
  • Long-term capital growth
  • Investment in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors.

* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.

For latest Riskometer, investors may refer to an addendum issued or updated on website at www.kotakmf.com

## Risk rate assumed to be 5.52% (FBIL Overnight MIBOR rate as on 30th June 2025). **Total Expense Ratio includes applicable B30 fee and GST.
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'